Abeona Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cleveland, OH
ABEO chart
What traders are saying about $ABEO
Latest postsAbeona Therapeutics Inc. news
- Form 144 ABEONA THERAPEUTICS INC. For: 25 October By Investing.com
Investing.com Nigeria ·
- Abeona Therapeutics Inc. Estimates – NASDAQ:ABEO
TradingView ·
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright
marketbeat.com ·
- Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum
marketbeat.com ·
- Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
Yahoo Finance ·
- ABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells
stocktwits.com ·
- Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
Yahoo Finance ·
- Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®
Yahoo Finance ·
- Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Yahoo Finance ·
- Abeona’s (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement Milestone
Yahoo Finance ·
- Abeona Therapeutics Inc (ABEO) (Q2 2026) Earnings Call Highlights: ZEVASKYN Revenue Surges 31% ...
Yahoo Finance ·
Abeona Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $5.8M | – | $3.5M | $1.4M |
| Net income | -$71.2M | $63.7M | $54.2M | -$39.7M |
| Diluted EPS | $1.01 | $-1.55 | $-2.53 | $-5.53 |
| Total assets (year end) | $219.6M | $108.9M | $64.0M | $64.2M |
| Cash and equivalents (year end) | $78.4M | $23.4M | $14.5M | $14.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Abeona Therapeutics Inc.
- Ticker
- ABEO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cleveland, OH
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 318306
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
Frequently asked questions
What exchange is Abeona Therapeutics Inc. listed on?
Abeona Therapeutics Inc. trades on the Nasdaq under the ticker symbol ABEO.
What industry is Abeona Therapeutics Inc. in?
Abeona Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Abeona Therapeutics Inc. headquartered?
Abeona Therapeutics Inc.'s business address on file with the SEC is in Cleveland, OH.
When does Abeona Therapeutics Inc.'s fiscal year end?
Abeona Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Abeona Therapeutics Inc. report?
Abeona Therapeutics Inc. reported $5.8M in revenue for calendar year 2025, according to its SEC filings.